Semaglutide is a synthetic peptide analog engineered to selectively mimic the activity of the glucagon-like peptide-1 (GLP-1) receptor, a key pathway involved in metabolic signaling and glucose regulation. Due to its targeted receptor interaction, Semaglutide has become a compound of significant interest within metabolic, endocrine, and peptide-based research fields.


Reviews
There are no reviews yet.